The total initial cost associated with newly diagnosed cancer for the healthcare system is $4.8 billion. Hospital episodes accounted for 80% of the healthcare expenditure, followed by PBS (13%) and MBS (5%).
Results, subheading "Results of Cost of cancer during the first 12-months post-diagnosis by population group", 2nd paragraph:
Indigenous Australians had significantly higher costs for ED presentations (23% higher), but significantly lower costs for MBS rebates (8% lower), PBS rebates (18% lower), and patient co-payments (61% lower) compared to non-Indigenous Australians. [The words "for hospital episodes (22%)" have been removed from the sentence].
The costs for hospital episodes were significantly higher in the first 12-months post-diagnosis with increasing remoteness, 4% for people living in inner and outer regional areas, and 10% higher for people living in remote and very remote areas compared to those living in metropolitan areas. [these percents were previously reported as 6% and 15% higher, respectively].
Compared to those living in the most disadvantaged areas (IRSD Q1), those in quintiles 4-5 had decreasing costs associated with hospital episodes [quintiles 3-4 were previously reported]. 
